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Environmental Factors and
Diseases of the Pancreas
by Daniel S. Longnecker*
The five major diseases of the pancreas together make a significant contribution to morbidity and
mortality among the people of the United States. These diseases are diabetes, cystic fibrosis, acute and
chronic pancreatitis, and carcinoma of the exocrine pancreas. Four of these diseases can be modeled in
laboratory animals by acute or chronic administration of chemical poisons or carcinogens. Human
pancreatic diseases attributed to the effect ofchemical agents including alcohol and drugs include many
cases ofchronic pancreatitis andsome cases ofacute pancreatitis. Thecause is not known in manycases of
human pancreatitis, including interstitial, acute, and chronic clinical forms. Epidemiologic studies sug-
gest that the increasing incidence ofcarcinoma ofthe exocrine pancreas in the United States may reflect
chemical carcinogenesis. On the basis of experimental observations, we know that pancreatic islet cells
can be damageddirectly by toxicchemicals, and that isletcell tumors can be chemically induced.
Thus, there is adequate background data to conclude that several pancreatic diseases of obscure
etiology may be due in part to hitherto unidentified toxic effects of chenical agents encountered in
personal or general environments.
The aggregate impact of five major diseases of
the pancreas on mortality and morbidity in the
United States is major. These diseases are diabetes,
cystic fibrosis, acute and chronic pancreatitis, and
carcinoma of the exocrine pancreas. The last of
these is clearly increasing in incidence and en-
vironmental influences are suspected of playing an
etiologic role. In an international survey of pancre-
atic diseases observed at autopsy, nearly two peo-
ple out of every 100 had apparently died from a
pancreatic disease (1), and the prevalence of dia-
betes as an underlying cause of disease has been
stressed (2).
Homeostasis and Disease
in Humans
The pancreas, which constitutes about 0.1% of
adult body weight, is highly specialized to synthe-
size and secrete several specific proteins. More
than 90%c of the gland consists of exocrine pancre-
atic acinar cells which are as active in protein syn-
thesis as any cell type in the body, secreting diges-
tive enzymes into the intestine through the pancre-
atic duct system. These hydrolytic enzymes, when
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activated within the pancreas, can digest protein,
RNA, DNA, phospholipids, carbohydrates, and
lipids at physiologic pH. This creates a special vul-
nerability of pancreatic acinar cells to injury which
can trigger activation and release of these enzymes
within the cell, resulting in cytoplasmic damage or
cell death. Minor degrees of injury seem to occur
regularly, resulting in autophagy and recovery of
the injured cell, or necrosis and loss of individual
acinar cells. The causes of acinar cell damage in-
clude ischemia, trauma, duct obstruction, nutri-
tional deficiency, metabolic abnormalities, virus in-
fection, and toxic chemicals. Acinar cells can di-
vide in experimental animals, and we assume that
regeneration can occur in the human. Initial sec-
tions of this paper focus on diseases of exocrine
pancreas, and a final section focuses on the pan-
creatic islets.
Pancreatitis
When many acinar cells are injured and their en-
zymes are released, virtually all ofthegland may be
destroyed. The resulting clinical disease, acute
hemorrhagic pancreatitis, may be fatal. Less severe
degrees ofthe process may destroy part ofthegland
and lead to scarring or pseudocyst formation. Mul-
tiple minor episodes may cause the majority of the
gland to be replaced by fibrous tissue so that en-
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digestivefunction inthe small intestine. Such scarred,
atrophic glands are characteristic of chronic pan-
creatitis. Milder degrees of acute pancreatitis in
which complete recovery is the rule also occur. This
disease is usually designated as interstitial pan-
creatitis.
Acute pancreatitis is a significant clinical prob-
lem because of associated mortality and morbidity
including the possible late complications indicated
above. The mortality rate among "first episodes"
of acute pancreatitis was 20% in a recent British
study (3).
Many cases of acute pancreatitis are associated
with biliary tract disease, which may lead to ob-
struction of the pancreatic duct by gallstones when
the two duct systems join in the head of the pan-
creas. Trapnell (3) tabulated the etiologic factors
among 590 cases ofacute pancreatitis (Table 1).
Table 1. Etiological factors in pancreatitis.
Etiological factor No. cases %
Biliary tract disease 316 53.6
Chronic alcoholism 26 4.4
Mumps 7 1.2
Hyperparathyroidism 1 0.2
Carcinoma 8 1.4
Steroids 6 1.0
Other 9 1.5
Not stated" 14 2.4
Idiopathic 203 34.4
TOTAL 590 100
aln these cases the presence or absence ofbiliary tract disease
had not been determined.
In this country, the proportion of cases associated
with biliary tract disease has been reported as lower
(37%), and that due to alcoholism as higher (19%)
(4). The incidence of episodes of acute pancreatitis
is high among chronic alcoholics. Fully one third of
cases of acute pancreatitis have no apparent cause,
and this so called "idiopathic" group probably re-
flects several different causes. Pancreatitis, like cir-
rhosis, is correctly regarded as several diseases in
regard toetiology.
There was no convincing evidence of increasing
incidence of acute pancreatitis in the period of
1950-1969 in Trapnell's study, nor during 1940-1969
in the similar, but smaller series from Minnesota
(4).
In this country, the majority of cases of chronic
pancreatitis, specifically the variant designated as
chronic calcifying pancreatitis, in which a specific
cause is known, result from chronic alcoholism.
According to the view of Henri Sarles, this reflects
multifocal obstruction of the pancreatic ducts
throughout the gland, and his detailed analysis of
the effects of alcohol on pancreatic secretion is
available in multiple reports and reviews (5, 6). His
views are not uncontested (7), but the relationship
between chronic alcoholism and chronic calcifying
pancreatitis seems well enough established so that
the incidence of the latter will reliably be propor-
tional to the former. Sarles defined chronic al-
coholism as a history ofdrinking a mean quantity of
150 ml of alcohol per day for at least two years.
Trapnell reports a rising proportion of cases of
acute pancreatitis among alcoholics in his study
spanning 1950-1969(3).
Although many cases ofchronic pancreatitis may
be chronic calcifying pancreatitis due to chronic al-
coholism it is usually accepted that some cases may
represent the end stage ofdamage accumulated dur-
ing multiple, recurrent episodes of nonfatal pan-
creatitis due to causes other than alcoholism. A re-
cent Japanese study indicates that etiology was un-
known in 4!.5% of 150 cases of chronic calcifying
pancreatitis, and an additional 11.3% had a history
of previous acute pancreatitis but were not al-
coholics (8). It follows that any toxic chemical cap-
able ofinducing pancreatitis with necrosis and scar-
ring could cause chronic pancreatitis if there were
multiple episodes of exposure and pancreatic in-
jury.
The exocrine pancreas appears to possess great
functional reserve. In patients with chronic pan-
creatitis, it appears that atrophy and scarring must
progress to the point that enzyme secretion is re-
duced below 10% of normal levels before malab-
sorption occurs and fecal fat and nitrogenous com-
pounds increase (9).
Cystic Fibrosis
Cystic fibrosis is a genetically determined and in-
herited systemic disease in which the pancreatic
changes may be characterized as a variant of
chronic pancreatitis induced by obstruction of in-
trapancreatic ducts by abnormal mucinous secre-
tions. This process begins in utero and progresses
to complete destruction and atrophy ofthe exocrine
pancreas during the first few years oflife. The gene
for cystic fibrosis is relatively common in the gen-
eral population: estimated to be about 1/20 among
Caucasians (10). This frequency has been inter-
preted as suggesting that there may be some selec-
tive advantage for heterozygotes (11). Another pos-
sibility is that this is a common mutation which is
continually being introduced into germ cells in the
population. While the conventional view is that
germ cells are remote and well protected from en-
vironmental mutagens, the possibility of inducing
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is real.
We do not have evidence that the incidence of
cystic fibrosis is rising in this country. Inability to
reliably recognize cystic fibrosis heterozygotes in
the general population has prevented assessment of
whether they are at high risk for development of
pancreatic or pulmonary disease under the influ-
ence ofenvironmental factors.
Anomalies and Aging
Developmental abnormalities including agenesis
of the exocrine pancreas and selective trypsinogen
deficiency have been described (12). Such rare
events could reflect teratogenic effects of external
agents, but no constant etiologic relationships have
been defined and the occurrence of such disorders
is sporadic. Although autopsy of aged individuals
sometimes reveals an apparent decrease in mass of
the exocrine pancreas, loss of endocrine function
with age seems to be a more significant considera-
tion than loss of exocrine function.
Carinoma ofthe Pancreas
Carcinoma ofthe pancreas is an increasingly prev-
alent form of human cancer (13, 14). Several
epidemiologic studies suggest that chemical car-
cinogens may induce pancreatic cancer in humans,
and several chemicals have been demonstrated to
induce carcinoma of the exocrine pancreas in ex-
perimental animals following systemic administra-
tion.
Bates has recently reviewed background consid-
erations relevant to chemical carcinogenesis in the
pancreas, and cites studies showing an increased
incidence of pancreatic cancer among workers oc-
cupationally exposed to f3-napthylamine or ben-
zidene, among chemists who were members of the
American Chemical Society (15) and among
cigarette smokers (16). Epidemiologic data indicate
that although the incidence of carcinoma of the
pancreas in Japan is low compared with that in the
USA, Japanese who have immigrated to the US
have a higher incidence than that ofthe native white
population of this country. Thus, environmental
factors appear to play a major role in the etiology of
carcinoma ofthe pancreas.
Experimental Toxicology and
Pancreatic Damage
Numerous chemical agents are known or sus-
pected to induce acinar cell damage or necrosis, to
alter acinar cell or duct cell function, or to induce
neoplastic change in the pancreas. These agents are
listed in Tables 2-5. A few generalizations and
summary comments are included here and will draw
on specific examples cited there.
Varying degrees of acute pancreatitis can be in-
duced in animals by giving chemicals which are
cytotoxic for acinar cells. Some systems closely
mimic the most severe forms of acute hemorrhagic
pancreatitis, e.g. ethionine administration in mice
fed a choline-deficient diet (31). Intermediate de-
grees of pancreatic necrosis simulating nonfatal de-
grees ofpancreatitis have been induced by puromy-
cin, azaserine, and hydroxyaminoquinoline
1-oxide, whereas lower doses of these and other
agents, or treatment with less cytotoxic agents may
induce milder degrees of damage analogous to
human interstitial pancreatitis. The list of agents
affecting the pancreas includes several amino acid
analogs. This group of compounds has a specific
propensity to affect the pancreas, probably because
ofthe pancreas' high affinity fora-amino acids. The
pancreas has been shown to concentrate both nor-
mal and several abnormal amino acids or amino
acid derivatives to a greater degree than most other
tissues. Alcohol, and perhaps cortisone, seem to
have minimal direct cytotoxic effects on the pan-
creas, but have been shown to alter pancreatic se-
cretions in a way which promotes protein precipita-
tion in the duct system leading to pancreatitis due to
duct obstruction.
Since about a third of cases of human acute pan-
creatitis are classed as idiopathic, it seems reasona-
ble to suspect that some of these cases may reflect
acute toxic effects of chemicals, food additives, or
drugs. Medical literature contains sporadic reports
of acute pancreatitis in association with specific
therapeutic products (Table 3). More detailed
analysis of possible occupational or environmental
exposure to toxic agents in patients with pan-
creatitis might lead to the identification of specific
causes in the "idiopathic group" of patients with
acute pancreatitis, and in non-alcoholic patients
with chronic pancreatitis.
Experimental models of induction of pancreatic
adenocarcinoma have been described using di-
propylnitrosamine derivatives, methylnitrosourea,
4-hydroxyaminoquinoline I-oxide, and azaserine
(Table 4). With this background, environmental ni-
trosamines should receive special scrutiny as possi-
ble pancreatic carcinogens.
Pancreatic Islets
The pancreatic islets of Langerhans are small
nodules of endocrine tissue dispersed throughout
the pancreas. They number an estimated 0.25-1.75
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Agent Effecta Species Reference
2-Acetylaminofluorene xRER rat Flaks (17)
4-Acetylaminofluorene xRER rat Flaks (18)
Actinomycin D xRER, AV, deg mouse Rodriquez (19)
Aflatoxin AV, xRER, deg rat Rao (20)
Azaserine xRER, AV, atr, nec rat Hruban (21)
Carbon tetrachloride nec, atr rat Veghelyi (22)
Chloroquine AV rat Fedorko (23)
Chlorothiazide pancreatitis mouse Cornish (24)
Cobalt chloride xRER, AV guinea pig Kern (25)
Cortisone AC atr, fat nec, rabbit Stumpf (26)
SENZ
Cycloleucine AV, xRER, deg rat Chenard (27)
Diethanolamine xRER, deg rat Hruban (28)
Ethanol duct obstruction rat Sarles (29)
xmito
Ethionine AC, AV, atr, deg, rat Farber (30)
nec, xRER, xmito mouse Lombardi (31)
guinea pig Wenk (32)
hamster Boquist (33)
Goldberg (34)
5-Fluorouracil AV, xRER, xmito rat Martin (35)
,f3-3-Furyl- DL -alanine xRER, AV, xmito rat Hruban (36)
4-Hydroxyaminoquinoline-1-oxide AC nec, SENZ guinea pig Reddy (37)
rat Konishi (38)
Methionine AV, fibrillar bodies, hamster Boquist (39)
atr, deg, xRER rat Kaufman (40)
Neutral red AV, xRER mouse Morgan (41)
Weiss (42)
Puromycin AC nec, xRER, AV rat Longnecker (43, 44)
/3-3-Thienyl- DL -alanine AV, xRER rat Hruban (45)
Triparanol AV, xRER, deg rat Hruban (28)
Vinblastine AV, AC atr mouse Nevalainen (46)
aThe observed effect is abbreviated as follows: AC = acinar cell; DC = ductal cell; IC = islet cell; nec= necrosis; atr =
atrophy; AV = autophagy; xRER = change in granular endoplasmic reticulum; xmito= mitochondrial change; SENZ =
elevation of serum enzymes from pancreas, e.g., amylase; deg = loss of secretory granules.
Table 3. Agents and drugs reported to cause
pancreatitis in humans.
Agent Effecta No. cases Reference
Azathiaprine AP 1 Breuer (47)
Chlorthalidone AP op 1 Jones (48)
Chlorothiazide AP, Lab Dx 4 Johnston (49)
Frusemide (Lasix) AP, RP, Lab Dx 2 Jones (50)
Wilson (51)
Immuran AP, RP, Lab Dx I Nogueira (52)
Oral contraceptives AP, Lab Dx 4 Davidoff (53)
aThe observed effect is abbreviated as follows: AP= acute
pancreatitis; IP = acute interstitial pancreatitis; CP = chronic
pancreatitis; RP = recurrent episode(s) of acute pancreatitis;
Lab Dx = diagnosis based on laboratory studies; op = operative
diagnosis.
Table 4. Agents reported to cause pancreatic
neoplasms in experimental animals.
Agent Effect0 Species Reference
Azaserine AC ca rat Longnecker (54)
2, 2'-Dihydroxydi-
N-propylnitro-
samine DC, AC ca hamster Pour (55)
N,N'-2-7-Fluo-
renylene-
bisacetamine AC ad rat Morris (56)
Heliotrine IC ad rat Schoental (57)
4-Hydroxyamino-
quinoline 1-oxide AC ad rat Hayashi (58)
AC ca rat Konishi (59)
N-Methyl-N-nitro-
sourea DC, AC ca guinea Reddy (60)
pig
Streptozotocin IC ad rat Rakieten (61)
aTheobserved tumorisabbreviatedasfollows AC = acinarcell;
DC = ductalcell; IC = isletcell;ad = adenoma; ca = carcinoma.
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the pancreas (62). In aggregate they function as an
endocrine organ regulating blood glucose levels and
cell metabolism. Islets consist of three major cell
types: p-cells make and secrete insulin in response
to rising plasma glucose levels, a-cells (sometimes
designated a2-cells) make and secrete glucagon,
and 8-cells (sometimes designated a,-cells) make
and secrete gastrin.
Islet cells are subject to damage by viral infec-
tions and toxic chemicals, and may respond by re-
versible degenerative changes or cell death. Islets
may also be destroyed incidental to diseases of the
exocrine pancreas because of the intimate associa-
tion of the two types of tissue. The prevalence of
decreasing ,-cell function with age suggests that is-
lets have a limited capacity to regenerate.
Diabetes is the major clinical syndrome reflecting
decreased islet cell function and more specifically
reflects deficiency of insulin secretion by p-cells.
Reduced secretion may reflect a decrease in the
number ofp3-cells or a decrease in insulin synthesis
and secretion by 8-cells. Several possible causes
are recognized for such decrease of p-cell function
in humans: an inherited genetic basis and destruc-
tion incidental to diseases ofthe exocrine pancreas.
While the most prevalent type of diabetes is re-
garded as a familial disease, the inheritance pattern
is complex, suggesting that several genes may be
involved (63). In addition, physiologic, nutritional,
and possibly environmental factors seem to influ-
ence the onset ofthe disease, e.g., obesity and age.
Experimental toxicology has demonstrated that
,p-cell destruction or dysfunction can be caused by
chemicals, e.g., alloxan, streptozotocin, cyprohep-
tadine, and others (see Table 5). These observa-
tions suggest that normal or genetically predisposed
individuals might lose p-cell function as a result of
environmental influences such as exposure to toxic
chemicals introduced into the environment or used
as drugs or food additives.
The incidence ofdiabetes increases with age, and
it may be that "aging" of islet cells is an important
factor in the development of adult onset diabetes.
Aging theory recognizes the accumulation ofsomatic
cell damage, e.g. somatic cell mutation, as a possible
basis for declining function. There is increasing evi-
dence that chemical mutagens can contribute to such
change in mammalian somatic cells.
The recent report ofthe National Commission on
Diabetes (71) should be consulted for an exhaustive
discussion of etiologic considerations and research
needs for this major disease.
There are no well-defined clinical syndromes re-
lated to decrease of a- or p-cell function. It is
known that a-cells may be damaged toxically by
chemicals such as cobalt. Thus while ,-cell damage
or dysfunction seems to constitute the major prob-
lem attributable to loss of islet cell function, it is
possible that other clinical problems will emerge or
be defined in the future.
Table 5. Agents reported to be cytotoxic for islet ceDls.
Agent Effect" Species Reference
Alloxan /8 nec several Dunn (64)
Cobalt chloride a deg several Fischer (65)"
Cyclizine 13,deg, rat Hruban (66)
xRER
Cyproheptadine /3 vac, deg rat Wold (67)
Streptozotocin ,3 nec several Rakieten (68)
N-Methyl-N-
nitrosoLurea nec (a,,8,8) hamster Wilander (69)
Berme (70)
"Abbreviations used are: ,8 = /8 cell; a = a cell; 6 = 8 cell; nec =
necrosis; deg = degranulation; xRER = change in granular
endoplasmic reticulum.
'This recent review provides an analytic discussion ofthe ettect
of most of the agents listed in this table.
Islet cell tumors constitute a second group of le-
sions causing human disease. This may be as-
sociated with hypersecretion of insulin, glucagon,
or gastrin leading to clinical syndromes attributable
to hormone excess, e.g., hypoglycemia, diabetes,
and secretory disturbances in the gastrointestinal
tract reflected as intractable peptic ulcers or
diarrhea. The causes of islet cell tumors remain as
obscure as the problem ofetiology ofcancer in gen-
eral. Islet cell tumors can be induced in experimen-
tal animals by streptozotocin and heliotrine (Table
4). Thus it is possible for chemical carcinogens to
affect islet cells under appropriate circumstances.
Detection of islet cell tumors in humans depends
on the biologic activity of the tumor. Hormone-
secreting tumors may be recognized during life be-
cause of clinical evidence of disturbed endocrine
function; however, nonfunctioning tumors may be
recognized only as a result of metastatic spread or
be found incidentally at autopsy.
Recommendations
The preceding considerations suggest several ap-
proaches which can be taken to further define the
causes of pancr-eatic diseases and possibly prevent
introduction of environmental hazards which might
further increase the incidence of these diseases.
Toxicologic evaluation of new chemicals to be
titilized in ways which will result in significant
hUman exposure should include evaluation of acute
and chronic effects on the pancreas in regard to the
October 1977 109following: (1) acinar cell cytotoxicity; (2) islet cell
cytotoxicity; (3) effects on the duct system or pan-
creatic secretions which will lead to duct obstruc-
tion; and (4) cancer induction. Evaluation should
include acute and chronic toxicologic studies for all
compounds and carcinogenesis bioassay for poten-
tial carcinogens. Since so many a-amino acid
analogs have been shown to affect the pancreas,
such compounds should be especially suspect in re-
gard to effects on acinar cells. Agents which are
structural analogs of glucose are particularly sus-
pect for potential endocrine effects because of the
likelihood that they may enter orbind to 8-cells via
glucose receptor pathways.
More sensitive and specific methods are needed
to detect "subclinical" degrees of acute acinar cell
injury and focal duct obstruction. Population
groups at risk from exposures to known pan-
creatoxic agents should be sought. Determination
ofurine and/or serum amylase levels seems to offer
the most practical initial screening approach at the
present time although this technique lacks specific-
ity for the pancreas. Fundamental research relating
to the pancreas should receive increased emphasis
and should be focused on the basic mechanisms of
toxic injury to pancreatic cells using models of
chemical injury to pancreases of animals on a
laboratory basis.
If situations arise in which chronic exposure to a
suspected toxin has occurred and there is aquestion
regarding exocrine pancreatic damage, the popula-
tion at risk should be screened for adequacy ofpan-
creatic function. Determination of fecal fat would
seem to offer one practical initial screening ap-
proach, although more sensitive methods to detect
decreased exocrine function should be sought.
Populations considered to be at risk for exposure
to any toxic agents suspected of affecting islets
should be screened or monitored by tests for
glycosuria and serum glucose determinations (fast-
ing or 2 hr postprandial); and further evaluated by
glucose tolerance testing ifabnormalities are found.
Data regarding the incidence ofmajor pancreatic
diseases indefined population groups should be col-
lected and analyzed. Ifthere is evidence ofincrease
in the incidence of any disease, the change should
be analyzed to see if there is evidence of an
etiologic role for any specific environmental agent
or factor.
It remains to be learned whether individuals who
are heterozygous for the gene for cystic fibrosis
are at special risk for the development of acute or
chronic pancreatitis. If this were true, then en-
vironmental factors not affecting the general popu-
lation might carry a special risk for this group.
Therefore, development of a reliable test for cystic
fibrosis heterozygotes is needed, since about 5% of
the population could be affected (72).
This material is drawn from a Background Document pre-
pared by the author for the NIEHS Second Task Force for
Research Planning in Environmental Health Science. The Re-
port of the Task Force is'an independent and collective report
which has been published by the Government Printing Office
under the title, "Human Health and Environment-Some Re-
search Needs." Copies of the original material for this Back-
ground Document, as well as others prepared for the report can
be secured from the National Technical Information Service,
U.S. Department ofCommerce, 5285 Port Royal Road, Spring-
field, Virginia 22161.
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